RT @carpe_diem0820: パンデミックの初期にニューヨークで治療を受けた重篤なCOVID-19患者で、ECMO を装着した患者 30 例のうち、27 例(90%)が退院まで生存し、26 例(86.7%)が離脱後 1 年まで生存と治療成績が良好だった 'Excep…
RT @carpe_diem0820: パンデミックの初期にニューヨークで治療を受けた重篤なCOVID-19患者で、ECMO を装着した患者 30 例のうち、27 例(90%)が退院まで生存し、26 例(86.7%)が離脱後 1 年まで生存と治療成績が良好だった 'Excep…
RT @carpe_diem0820: パンデミックの初期にニューヨークで治療を受けた重篤なCOVID-19患者で、ECMO を装着した患者 30 例のうち、27 例(90%)が退院まで生存し、26 例(86.7%)が離脱後 1 年まで生存と治療成績が良好だった 'Excep…
RT @carpe_diem0820: パンデミックの初期にニューヨークで治療を受けた重篤なCOVID-19患者で、ECMO を装着した患者 30 例のうち、27 例(90%)が退院まで生存し、26 例(86.7%)が離脱後 1 年まで生存と治療成績が良好だった 'Excep…
RT @carpe_diem0820: パンデミックの初期にニューヨークで治療を受けた重篤なCOVID-19患者で、ECMO を装着した患者 30 例のうち、27 例(90%)が退院まで生存し、26 例(86.7%)が離脱後 1 年まで生存と治療成績が良好だった 'Excep…
パンデミックの初期にニューヨークで治療を受けた重篤なCOVID-19患者で、ECMO を装着した患者 30 例のうち、27 例(90%)が退院まで生存し、26 例(86.7%)が離脱後 1 年まで生存と治療成績が良好だった 'Exceptional' ECMO Outcomes in COVID-19 Reflect Early Choices https://t.co/DqXCdOYNAl https://t.co/be3CHwjqNU
RT @UMInternalMed: We’re looking forward to our virtual journal club today! Two of our third years will be presenting. Mary will present on…
We’re looking forward to our virtual journal club today! Two of our third years will be presenting. Mary will present on #ECMO in #COVID19 https://t.co/ZYQuJedsMB. Amanda will present on the #YEARS rule for PE diagnosis https://t.co/xQuC9on3di. Residents,
RT @carpe_diem0820: 41カ国で治療を受けたCOVID-19患者約5000人のECMO登録を調査 2020年5月以降に体外式膜酸素療法(ECMO)を導入した医療機関では、死亡率が50%を超過 ECMOの導入の検討する際に有用な情報 Higher Mortal…
41カ国で治療を受けたCOVID-19患者約5000人のECMO登録を調査 2020年5月以降に体外式膜酸素療法(ECMO)を導入した医療機関では、死亡率が50%を超過 ECMOの導入の検討する際に有用な情報 Higher Mortality in COVID-19 Patients Who Received ECMO Later in the Pandemic https://t.co/2etI6sFH6N https://t.co/dJPGRR0aUG
RT @carpe_diem0820: COVID-19重症呼吸不全患者の多施設コホート研究 ICU入室後最初の7日間にECMOを導入した重度低酸素血症(PaO2/FiO2 < 100)患者は院内死亡率が低い(HR0.55;95% CI 0.41-0.74) Extracor…
RT @FOAMecmo: 3⃣ECMO in #COVID19 related severe respiratory failure: 190 runs 66.8% survival https://t.co/pX67GLh5Mq 4⃣#ECMO vs convention…
RT @FOAMecmo: 3⃣ECMO in #COVID19 related severe respiratory failure: 190 runs 66.8% survival https://t.co/pX67GLh5Mq 4⃣#ECMO vs convention…
RT @FOAMecmo: 3⃣ECMO in #COVID19 related severe respiratory failure: 190 runs 66.8% survival https://t.co/pX67GLh5Mq 4⃣#ECMO vs convention…
RT @FOAMecmo: 3⃣ECMO in #COVID19 related severe respiratory failure: 190 runs 66.8% survival https://t.co/pX67GLh5Mq 4⃣#ECMO vs convention…
5/@doctorbrijpatel:Características clínicas y desenlaces con #ECMO en 5,122 pts críticos #COVID19 e hipoxemia grave: -Después de 60 días: -Mortalidad ~34%, -Recuoeración ~67% #ATS2021 👉 https://t.co/g4ugud6oha https://t.co/hzrgsW1Tx7
RT @FOAMecmo: 3⃣ECMO in #COVID19 related severe respiratory failure: 190 runs 66.8% survival https://t.co/pX67GLh5Mq 4⃣#ECMO vs convention…
3⃣ECMO in #COVID19 related severe respiratory failure: 190 runs 66.8% survival https://t.co/pX67GLh5Mq 4⃣#ECMO vs conventional strategies in severe #ARDS: ECLS pts more days alive out #ICU & w/o system/organ failure https://t.co/GfQk3hddAE Both on @yo
RT @ccanesth: #JournalWatch #CritCareAnesthesiology 3.7% of 5,122 ICU patients with COVID-19 respiratory failure received ECMO treatment i…
@basakcoruhUW @leticiakawano @f_g_zampieri @azevedo_lcp @PauloNassar1 @israelmaia16 @virenkaul @GallodeMoraesMD @FlaviaSepsis @laxswamy Here’s another paper for the discussion @SShaefi @megan_krajewski https://t.co/7AeGwSQwcc
#JournalWatch #CritCareAnesthesiology 3.7% of 5,122 ICU patients with COVID-19 respiratory failure received ECMO treatment in this multicentre study in @yourICM. The mortality of ECMO patients was 34.6% vs. 47.4% of the cohort with PaO2/FiO2 <100. http
Extracorporeal membrane oxygenation saves lives in patients with CV-19 respiratory failure (not surprising). https://t.co/HnUyhdKb5N "In the primary analysis, patients who received ECMO had lower mortality than those who did not (HR 0.55; 95% CI .41–.74)"
RT @AeroMedicine: In select patients with severe respiratory failure from COVID-19, ECMO may reduce mortality. https://t.co/lJvWfRYeDt #pan…
In select patients with severe respiratory failure from COVID-19, ECMO may reduce mortality. https://t.co/lJvWfRYeDt #pandemic #ICU #ECMO
RT @_MiguelHernan: Good news from the STOP-COVID team: Extracorporeal membrane oxygenation (ECMO) was estimated to reduce mortality by 45…
RT @CGSNabzdykMD: Extracorporeal membrane oxygenation in COVID-19. More evidence that it can be useful in selected patients. https://t.co/…
Extracorporeal membrane oxygenation in COVID-19. More evidence that it can be useful in selected patients. https://t.co/t83CS2BrDI
RT @_MiguelHernan: Good news from the STOP-COVID team: Extracorporeal membrane oxygenation (ECMO) was estimated to reduce mortality by 45…
RT @_MiguelHernan: Good news from the STOP-COVID team: Extracorporeal membrane oxygenation (ECMO) was estimated to reduce mortality by 45…
RT @_MiguelHernan: Good news from the STOP-COVID team: Extracorporeal membrane oxygenation (ECMO) was estimated to reduce mortality by 45…
RT @_MiguelHernan: Good news from the STOP-COVID team: Extracorporeal membrane oxygenation (ECMO) was estimated to reduce mortality by 45…
RT @AmbrizMau: En esta cohorte multicéntrica de pacientes seleccionados con insuficiencia respiratoria grave por COVID-19, la Oxigenación p…
RT @DrVadimG: ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @…
RT @DrVadimG: ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @…
RT @BotaIntensiv: 2/3 überlebten in dieser Studie eine ECMO Behandlung bei #COVID19 (zumindest 60Tage). Allerdings sehr junges Kollektiv. D…
RT @BotaIntensiv: 2/3 überlebten in dieser Studie eine ECMO Behandlung bei #COVID19 (zumindest 60Tage). Allerdings sehr junges Kollektiv. D…
RT @DrVadimG: ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @…
RT @DrVadimG: ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @…
Very interesting 👌🏻
2/3 überlebten in dieser Studie eine ECMO Behandlung bei #COVID19 (zumindest 60Tage). Allerdings sehr junges Kollektiv. Deckt sich das mit Euren Erfahrungen @dscharpfMD? https://t.co/esnsu8ANig
RT @DrVadimG: ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @…
年齢群低っ 日本からのデータも見たいですねー
RT @DrVadimG: ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @…
RT @ECMOdaily: @yourICM #ECMO in #COVID19
RT @DrVadimG: ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @…
If early...#ECMO en covid
ECMO saves lives in COVID! Careful patient selection and management are the key factors in improved outcomes. @NidaQadirMD @UCLAAnes @UCLAPCCM
RT @AmbrizMau: En esta cohorte multicéntrica de pacientes seleccionados con insuficiencia respiratoria grave por COVID-19, la Oxigenación p…